The Influence of Estradiol Supplementation During the Luteal in Patients Undergoing IVF Treatment
Blinded Randomised Trial About the Influence of Estradiol Supplementation During the Luteal in Patients Undergoing in Vitro Fertilization (IVF) Treatment
1 other identifier
interventional
120
1 country
1
Brief Summary
To evaluate whether treatment with Estradiol supplementation during the luteal phase improves IVF outcomes Patients undergoing IVF treatment with controlled ovarian hyperstimulation using a GnRH analog will receive 4 mg estradiol valerate in the luteal phase.Patient's followup will include E2 progesterone and BHCG 14 days after embryo transfer and vaginal ultrasound on day 21 and 28 after embryo transfer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Aug 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 20, 2007
CompletedFirst Posted
Study publicly available on registry
June 22, 2007
CompletedStudy Start
First participant enrolled
August 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedJune 26, 2007
June 1, 2007
June 20, 2007
June 24, 2007
Conditions
Keywords
Outcome Measures
Secondary Outcomes (1)
E2 and progesterone levels
Interventions
Eligibility Criteria
You may qualify if:
- Women treated for infertility with controlled ovarian hyperstimulation using daily GnRH agonist
You may not qualify if:
- Women younger then 18 or older then 40
- Women with systemic disease
- Women with a family or personal history of thromboembolic event
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Infertilty unit, Assaf-Harofeh Medical Center
Ẕerifin, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rephael Ron-el, profesor
Assaf-Harofeh Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
June 20, 2007
First Posted
June 22, 2007
Study Start
August 1, 2007
Study Completion
August 1, 2008
Last Updated
June 26, 2007
Record last verified: 2007-06